Sanofi Sa
1 member of Congress bought
Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a collaboration and license agreement with Exscientia to develop small-molecule for oncology and…
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-03-30 | Alan Armstrong · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2025-09-11 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-08-04 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-07-22 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2024-09-04 | John James · R-MI | House | Sold | $1,001 - $15,000 |
| 2023-11-10 | John James · R-MI | House | Bought | $1,001 - $15,000 |
| 2023-07-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-02-27 | Daniel S. Goldman · D-NY | House | Sold | $1,001 - $15,000 |
| 2022-05-27 | Earl Blumenauer · D-OR | House | Bought | $15,001 - $50,000 |
Show the other 4
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-03-16 | John H. Rutherford · R-FL | House | Sold | $1,001 - $15,000 |
| 2020-03-19 | Greg Gianforte · R-MT | House | Bought | $1,001 - $15,000 |
| 2017-06-15 | Patty Murray · D-WA | Senate | Sold | $1,001 - $15,000 |
| 2017-03-16 | Patty Murray · D-WA | Senate | Bought | $1,001 - $15,000 |
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.